BHB-1893 - Braveheart Bio
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Aug 25, 2026 - P2 | N=84 | Completed | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Trial completion date: Aug 2025 ➔ Nov 2025 | Trial primary completion date: Aug 2025 ➔ Nov 2025 | Recruiting ➔ Completed 
Trial completion • Trial completion date • Trial primary completion date • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Non-obstructive Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT06816251
 
Aug 25, 2026
 
Prev Next